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Antimicrobial peptides (AMPs) have been proposed as a novel class of antimicrobials
that could aid the fight against antibiotic resistant bacteria. The mode of action of
AMPs as acting on the bacterial cytoplasmic membrane has often been presented as
an enigma and there are doubts whether the membrane is the sole target of AMPs.
Progress has been made in clarifying the possible targets of these peptides, which is
reported in this review with as focus gram-positive vegetative cells and spores. Numerical
estimates are discussed to evaluate the possibility that targets, other than themembrane,
could play a role in susceptibility to AMPs. Concerns about possible resistance that
bacteria might develop to AMPs are addressed. Proteomics, transcriptomics, and other
molecular techniques are reviewed in the context of explaining the response of bacteria
to the presence of AMPs and to predict what resistance strategies might be. Emergent
mechanisms are cell envelope stress responses as well as enzymes able to degrade
and/or specifically bind (and thus inactivate) AMPs. Further studies are needed to address
the broadness of the AMP resistance and stress responses observed.
Keywords: cationic antimicrobial peptides, mode of action, Bacillus subtilis, Bacillus subtilis spores, resistance
mechanisms
INTRODUCTION
Most antibiotics used today are compounds that were discovered during the 1940s to 1960s (Lewis,
2013). With the rise of antibiotic resistance the search for alternative antibiotics became a priority
to enable the treatment of imminent antibiotic resistant strains. It is in addressing this urgency that
antimicrobial peptides (AMPs) have been proposed as a possible candidate for use as antimicrobial
agents since their mode of action is presumed to be substantially different from existing antibiotics.
AMPs are, or are based on, natural molecules and are present in many organisms, ranging
from microorganisms to humans, where they are an essential part of the innate immune system
(Fox, 2013). The peptides have a broad-spectrum of activity as they are active against gram-
positive and gram-negative bacteria as well as fungi (Wimley and Hristova, 2011). AMPs can
be grouped based on their structure, which may be α-helical, β-sheet, cyclic, or adopt a more
extended peptide conformation (Nguyen et al., 2011a,b; Wilmes et al., 2014). Extended peptides
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do not fold into a secondary structure (Nguyen et al., 2011b).
Even though AMPs differ in sequence and structure, they share
common features, which are their overall cationic charge, a
significant fraction of hydrophobic residues and an ensuing
amphipathic character (Nguyen et al., 2011b). It is the cationic
properties that promote the preferential binding of AMPs to the
negatively charged bacterial cytoplasmic membrane instead of
the zwitterionic membrane of mammalian cells (Nguyen et al.,
2011b). When the AMP reaches the lipid membrane interface
of the target microorganism, the peptide takes an amphipathic
conformation due to the hydrophobic residues (Papo and Shai,
2003; Bowdish et al., 2005; Teixeira et al., 2012), thus enabling
the integration of the AMP into the membrane or the traversing
thereof. AMPs usually disrupt the cytoplasmic membrane, but
reports have been made of AMPs that seem to merely pass the
membrane to target intracellular processes such as DNA, RNA,
and protein synthesis (Park et al., 1998; Krijgsveld et al., 2000;
Xiong et al., 2002).
Most research has been focused on the use of model
membrane systems such as lipid vesicles, to determine the mode
of action of AMPs. Even though this knowledge is essential in
our understanding of the mode of action of AMPs, it does not
fully explain their interaction with microbial membranes nor
the response of microbes to the presence of AMPs. To address
these two aspects, the current knowledge about the interaction
of AMPs with bacterial cells and the response of bacteria to the
presence of AMPs will be reviewed. Gram-positives are our main
focus using Bacillus subtilis as model organism for pathogenic
microbes such as Staphylococcus aureus and the spore forming
Clostridium difficile. Knowledge concerning the antimicrobial
activity of AMPs against gram-positive spores is limited and
progress that has been made so far will be discussed. We
briefly outline the cellular organization of gram-positive bacteria
and spores of our model organism Bacillus to set the scene.
Subsequently we will report on the cellular targets of AMPs and
current knowledge about the response of gram-positives against
AMPs. Information concerning gram-negatives will be presented
wherever there is a lack of information about gram-positives
bacteria.
GRAM-POSITIVE VEGETATIVE CELL AND
SPORE COMPOSITION
Cell Envelop of Gram-Positives
The cell envelope of a bacterium is the major line of defense
against environmental threats. For gram-positives, the envelope
consist of the cell wall and cytoplasmic membrane (Figure 1).
Cell Wall of Gram-Positive Bacteria
Compared to gram-negative bacteria, gram-positive species have
a thicker cell wall of 30–100 nm width (Silhavy et al., 2010).
The cell wall of B. subtilis consist of a thick peptidoglycan layer
(±46% per dry cell weight) in which teichoic acids (±54% per
dry cell weight) are embedded (Graham and Beveridge, 1994, and
references therein). The protein fraction of the wall is±10% of all
cellular protein (Merchante et al., 1995). The B. subtilis cell wall
structure is dynamic as it is continuously being synthesized and
hydrolyzed during cell growth and cell division at the cytoplasmic
membrane (Mobley et al., 1984; Merad et al., 1989; Graham and
Beveridge, 1994; Banzhaf et al., 2012; Gray et al., 2015).
The peptidoglycan layer consists of linear glycan strands
of alternating disaccharide-peptide repeats coupled through
glycosidic bonds (Silhavy et al., 2010). These disaccharide-
peptide repeats are of N-acetylglucosamine (GlcNAc) and N-
acetylmuramic acid (MurNAc) residues and are coupled through
β-1,4 glycosidic bonds (Vollmer et al., 2008). The glycan
strands vary only slightly between different bacterial species,
but the peptidoglycan differs considerably in the stem peptides
composition and cross-links (Scheffers and Pinho, 2005). More
information concerning the structure and synthesis of the cell
wall can be found in various reviews (Scheffers and Pinho, 2005;
Lee and Huang, 2013).
The teichoic acids comprise of wall teichoic acids and
lipoteichoic acids (LTA). Wall teichoic acids are covalently
connected to the peptidoglycan layer. LTA are macroamphiphiles
that anchor in the membrane with their glycolipid and attach
to the cell wall with their polyglycerol chains (Neuhaus and
Baddiley, 2003). In B. subtilis teichuronic acid can also be
found, but it is thought to only be present under low-phosphate
conditions (Bhavsar and Brown, 2006).
Cell Membrane of Gram-Positive Bacteria
The cell membrane of B. subtilis in its stationary growth phase
consists of protein (±62% per dry cell weight), membrane
associated RNA (±22% per dry cell weight), and phospholipid
(±16% per dry cell weight) (Bishop et al., 1967). According
to the database Subtiwiki 2.0 (http://subtiwiki.uni-goettingen.
de/) about 721 proteins are localized at the cell membrane and
have various functions. The phospholipid composition of the
membrane of B. subtilis, of cells in their exponential growth
phase in LB medium, consist of ±10% cardiolipin (CL), ±25%
phophatidylglycerol (PG), ±50% phosphatidylethanolamine
(PE), and ±15% lysyl-phosphatidylglycerol (lysyl-PG) (López
et al., 2006). Cardiolipin and PG are negatively charged (−2
and −1, respectively), lysyl-PG positively charged (+1) and
the other phospholipids are zwitterionic (neutrally charged)
(Salzberg and Helmann, 2008). About 35% of the total
membrane phospholipids contribute to the negative charge of
the membrane, and only 15% contribute to the positive charge,
therefore the net charge of the cell membrane is negative since
the rest is zwitterionic (López et al., 2006).
Gram-positive bacteria are capable of modifying their
membrane composition to increase or reduce the net charge. For
instance, the membrane composition can change between the
growth phase or between cultures grown in different media. B.
subtilis cultured to its stationary growth phase has a membrane
consisting of ±25% CL, ±40% PG, ±20% PE, ±15% lysyl-
PG (López et al., 2006). Therefore, the negatively charged
phospholipids increase by±30% compared to the cell membrane
compositions observed during the exponential growing phase.
When cultured in LB medium with or without 1.5 M NaCl
(high salinity), B. subtilis increased the relative amounts of cell
membrane CL by ±20% decreasing the PE to ±17% (López
et al., 2006). The PG content was similar (±24%) and lysyl-PG
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FIGURE 1 | The composition of Bacillus subtilis vegetative cells. Image adjusted from Silhavy et al. (2010).
decreased only by ±5% (López et al., 2006). Therefore, the net
negative charge of the cell membrane was increased.
Cytoplasm of Gram-Positive Bacteria
The cytoplasm of gram-positive bacteria mainly consist of
the nucleoid and ribosomes. The nucleoid forms a dense
central mass of DNA loops with the transcriptional machinery
and ribosomes nearby (Lewis et al., 2000). The content
of intracellular ribosomes, protein, RNA, or mobile genetic
elements has, quantitatively, not generically been reported.
Reported chromosome sizes of B. subtilis are 4215 kb (Logan and
De Vos, 2015), of S. aureus 2814 kb (Kuroda et al., 2001), and of
C. difficile 4290 kb (Sebaihia et al., 2006).
Spores of Gram-Positive Bacteria
Mainly bacteria from the genera Bacillus and Clostridium
undergo the process of sporulation in response to nutrition
limitation (Higgins and Dworkin, 2012). During sporulation
some cells divide asymmetrically into a forespore and mother
cell (Piggot and Hilbert, 2004). The result of sporulation is the
production of a metabolically inactive or dormant endospore
that is upon its release from the mother cell capable of resisting
various environmental conditions such as extreme temperatures,
desiccation, and ionizing radiation (Higgins and Dworkin,
2012). For more information concerning the sporulation process
various reviews can be consulted (Piggot and Hilbert, 2004;
Higgins and Dworkin, 2012; McKenney et al., 2013; Tan and
Ramamurthi, 2014).
The structure of spores differs from that of vegetative cells,
consisting of exosporium (depending on the species), spore
coat, outer membrane, a cortex, a germ cell wall (GCW), inner
membrane, and central core (Figure 2) (Setlow, 2006). The
exosporium consists mostly of proteins and is not found in
all species, for instance it is absent in B. subtilis but present
in Bacillus cereus and Bacillus anthracis (Setlow, 2006). Under
the exosporium is the spore coat and in the case of B. subtilis
the spore coat consists of two layers known as the outer and
inner spore coat, which mainly consist of proteins (±30%
of total spore proteins) (Driks, 1999; Henriques and Moran,
2000, 2007; Abhyankar et al., 2014). The spore coat protects
the inner spore parts against various chemical and physical
stresses (Henriques and Moran, 2007), but also interacts with
the environment to facilitate the determination of favorable
environmental conditions for initiation of spore germination
(Henriques and Moran, 2007). Below the spore coat is the outer
membrane, which is essential for spore formation (Piggot and
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FIGURE 2 | The composition of Bacillus subtilis spores. Image adjusted from McKenney et al. (2013).
Hilbert, 2004) but is not an important permeability barrier like
the inner membrane (Setlow, 2006).
The spore cortex consists of two layers with the layer
close to the inner membrane being the GCW (Popham, 2002).
The GCW has a PG composition similar to the cell wall of
vegetative cells. However, the thick outer PG layer covering the
GCW is the cortex, which has different structural modifications
compared to the vegetative cell wall (Popham, 2002). Prominent
differences are the absence of teichoic acids and no crosslinking
of the glycan strands (Popham, 2002). During germination the
cortex is quickly degraded (Atrih et al., 1996; Popham et al.,
1996; Atrih et al., 1998; Meador-parton and Popham, 2000;
Popham, 2002) and the GCW becomes part of the vegetative
cell wall (Atrih et al., 1996; Meador-parton and Popham, 2000).
Cortex degradation results in the rehydration of the spore
core, followed by metabolic activity and loss of the spore’s
protection against the external environment (Popham, 2002;
Setlow, 2014).
The inner membrane of the spore is a resilient permeable
barrier and is key in protecting the DNA within the core against
damage (Setlow, 2006). The inner membrane is compressed and
can double in volume during the initial stages of germination
(Setlow, 2006). The lipid composition of the inner membrane is
the same as that of vegetative cells but it is immobile and becomes
fluid only during spore germination (Setlow, 2006). Zheng et al.
(2016) have recently published an extensive proteomics study
characterizing the inner membrane proteome and found that the
protein composition of the inner membrane and of the vegetative
cell membrane differs significantly.
The core of the spore contains macromolecules similar to
those in vegetative cells, including DNA, ribosomes, and tRNA
(Setlow, 2006). In contrast to vegetative cells, spores contain
pyridine-2,6-dicarboxylic acid (dipicolinic acid, DPA) and small,
acid-soluble spore proteins (SASP) (Setlow, 2006). DPA is 5–15%
of the dry weight of spores and SASPs cover 3–6% of the total
spore protein (Setlow, 2006). Both SAPs and DPA play a key role
in protecting the DNA (Setlow, 2006) whilst in the spore. During
germination DPA is released (Setlow, 2003) and during the early
stages of spore outgrowth SASPs are degraded and used as carbon
source for outgrowth (Setlow, 2006; Sinai et al., 2015).
AMPs TARGETING THE GRAM-POSITIVE
CELL WALL
The anionicity of the surface of B. subtilis is determined by
the presence of peptidoglycan and teichoic acids (Neuhaus and
Baddiley, 2003) and thus the first contact of cationic AMPs with
the bacterium is through electrostatic interaction. The anionic
nature of the B. subtilis cell wall is proposed to be due to
the presence of carboxyl groups of the muramyl peptides of
peptidoglycan and the carboxyl and phosphate groups of the
teichoic acids (Sonnenfeld et al., 1985). These anionic groups are
positioned toward the outside of the cell wall (Sonnenfeld et al.,
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1985). The role that peptidoglycan plays, other than attracting
the cationic peptide, is unknown. However, the importance of
(derivatives of) teichoic acids in the binding of cationic AMPs
became evident when the deletion of the dlt operon of S. aureus
caused a reduction in efficacy of various AMPs against the
bacterium (Peschel et al., 1999). The dlt operon mediates the
addition of D-alanine esters to teichoic acids (Neuhaus and
Baddiley, 2003).
Cell wall biosynthesis are, however, inhibited due to the
binding of AMPs to lipid II, a cell wall synthesis precursor
molecule. During the biosynthesis of the cell wall, uridine
diphosphate (UDP)-MurNAc-pentapeptide is produced in the
cytoplasm (Scheffers and Pinho, 2005; Bhavsar and Brown,
2006; Schneider et al., 2010). UDP-MurNAC-pentapeptide is
transferred to a membrane acceptor bactoprenol, resulting in the
formation of lipid I, which is converted to lipid II by the addition
of GlcNAc from UDP-GlcNAc to MurNAc. Lipid II, after the
addition of an interpeptide bridge in the case of gram-positives, is
translocated to the outer side of the membrane and incorporated
into the peptidoglycan chain. Similar to nisin, plectasin showed
to bind to lipid II thus preventing its incorporation into the
peptidoglycan chain (Schneider et al., 2010). Plectasin differed,
however, from nisin as its hydrophobic part was located at
the membrane interface whereas nisin inserts deep within the
membrane bilayer to cause delocalization of lipid II (Hsu et al.,
2004; Hasper et al., 2006; Schneider et al., 2010). Plectasin did not
cause membrane damage or dissipate the membrane potential
(Schneider et al., 2010). Human β-defensin 3 (hBD3) also
showed to interfere with cell wall biosynthesis, without causing
membrane damage. It prompted the accumulation of UDP-
MurNAc-pentapeptide in the cytoplasm, triggered the formation
of protrusions filled with cytoplasm through cell wall lesions,
inhibited proteins involved in the formation of lipid II (FemX
and penicillin-binding protein 2 [PBP2]), and bound to lipid
II though electrostatic interaction (Sass et al., 2010). Similar
cell wall biosynthesis inhibition due to lipid II binding was
observed for α-defensin human neutrophil peptide-1 (HNP1)
(De Leeuw et al., 2010). More information concerning the origin,
characteristic, and target of peptides mentioned in the text can be
found in Table 1.
AMPs also indirectly target the cell wall by triggering autolysis
of bacterial cells, which is the process when cells release
autolysins, that cleave peptidoglycan, resulting in the destruction
of itself. LTA, located at the septum, regulate autolysins and
have shown to release autolysins when disturbed by AMPs
(Bierbaum and Sahl, 1985, 1987; Wilmes et al., 2014). The
TABLE 1 | Additional information concerning antimicrobial peptides and other antimicrobials mentioned in the texts.
Peptide Origin Characteristic Target Reference and references therein
LL-37 Human α-helical Membrane Sochacki et al., 2011
tPMP Rabbit blood platelets α-helical Membrane Xiong et al., 2005, 2006
Thrombocidin Human blood platelets α-helical, Membrane Krijgsveld et al., 2000
Defensin Mammalian α-helical, β-sheets Membrane Peschel et al., 2001
β-defensin 3 (hBD3) Human β-sheets Cell wall Sass et al., 2010
α-defensin neutrophil
peptide-1 (HNP1)
Human α-helical Cell wall De Leeuw et al., 2010
θ-Defensins Old world monkeys
leukocytes
Cyclic Membrane Wilmes et al., 2014
Protegrin (PG-1) Porcine leukocytes β-sheet Membrane Bellm et al., 2000; Bolintineanu et al., 2010
Cecropin A Hyalophora cecropia
(a moth)
α-helical Membrane Rangarajan et al., 2013
Daptomycin Streptomyces roseosporus Cyclic lipopeptide Membrane Steenbergen et al., 2005
Indolicin Bovine neutraphils Extended wedge-like
conformation
Membrane Staubitz et al., 2001; Nicolas, 2009
MP196 Synthetic hexapeptide Linear peptide Membrane Wenzel et al., 2014, 2015
SMAP-29 Synthetic peptide derived
from cathelicidin
α-helical Membrane Skerlavaj et al., 1999
Nisin Lactococcus lactis Lantibiotic Membrane, cell wall biosynthesis Bierbaum and Sahl, 2009
Subtilin Bacillus subtilis Lantibiotic Membrane, cell wall biosynthesis Bierbaum and Sahl, 2009
Gallidermin Staphylococcus gallinarum Lantibiotic Membrane, cell wall biosynthesis Kellner et al., 1988; Bonelli et al., 2006
Plectasin Pseudoplectania nigrella α-helical, β-sheet Cell wall biosynthesis Mygind et al., 2005; Schneider et al., 2010
Mersacidin Bacillus sp. strain HIL
Y-8,554,728
Lantibiotic Cell wall biosynthesis Brötz et al., 1995, 1998
Actagardine or Gardimycin Actinoplaes garbadinensis Lantibiotic Cell wall biosynthesis Brötz et al., 1995; Somma et al., 1977
Vancomycin Streptomyces toyocaensis Glycopeptide Cell wall biosynthesis Mascher et al., 2004
Bacitracin Bacillus sps. Cyclic dodecylpeptide Cell wall biosynthesis McDermott et al., 2003; Hiron et al., 2011
Mundticin KS Enterococcus mundtii Bacteriocin Unknown (possibly membrane) Kawamoto et al., 2002; Sakayori et al., 2003
SP1-1 Synthetic peptide α-helical Serine kinase inhibition Dangel et al., 2013
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glycolipid anchor plays an important role in the inhibitory
effect of LTA on autolysins (Fischer et al., 1981) and this
is probably due to the disturbance of the cell membrane by
AMPs causing a delocalization of the glycolipid anchor. The
additional importance of anionic phosphodiester groups of LTA
were established when replacing it with D-alanine caused the
release of autolysins, but replacing the same positions with non-
charged glycosyl residues had no effect on the inhibitory action of
LTA. This finding is, however, in contrast with previous findings
that reports that the addition of D-alanine to the teichoic acids
reduces the efficacy of AMPs, as mentioned above. Lantibiotics,
Pep5, and nisin, have shown to cause autolysis, and an AMP from
Old world monkey leukocytes, θ-Defensins (Bierbaum and Sahl,
1985, 1987; Wilmes et al., 2014).
AMPs’ INTERACTION WITH THE
GRAM-POSITIVE CELL MEMBRANE
Cationic AMPs are attracted to the cell membrane through
electrostatic interaction, therefore focus has been placed mainly
on the phospholipid composition of cells. Various models have
been proposed for the interaction of AMPs with membranes and
have been extensively reviewed (Nguyen et al., 2011b; Wimley
and Hristova, 2011). For example, the barrel-stave model suggest
that peptides accumulate on the surface of the membrane and
insert into the membrane when a threshold amount is reached
(Nguyen et al., 2011b). The toroidal pore model proposes that
a peptide-and-lipid-lined pore is formed whereas the disordered
toroidal pore model suggests that the peptide causes pore
formation stochastically requiring less peptides per inferred pore
(Nguyen et al., 2011b). However, these models are based on
studies performed on lipid vesicles and cannot fully explain
the interaction of AMPs with the complex bacterial cytoplasmic
membrane.
AMPs act on vegetative cells causing membrane damage
and ensuing loss of transmembrane potential and essential
molecules (Nakajima et al., 2003; Bolintineanu et al., 2010; Lee
et al., 2015). Membrane damage has been shown to perturb
cellular homeostasis leading to either increase in cellular volume
(Bolintineanu et al., 2010) or cause shrinking of cells (Wang
et al., 2013). Pore or channel formation in cells has been
shown using fluorescent dyes such as propidium iodide (Wang
et al., 2013; Garg et al., 2014) and Sytox R© Green (Barns and
Weisshaar, 2013). Abnormal septum formation (Friedrich et al.,
2000; Nakajima et al., 2003) and blebbing (Skerlavaj et al., 1999)
has been observed with TEM. Blebbing is the formation of
membrane bulges when the cytoskeleton is detached from the
cell membrane causing the latter to swell. In the case of S. aureus
treated with SMAP-29, blebbing occurred frequently at the sites
of cell division (Skerlavaj et al., 1999). Still, generally these studies
only confirm membrane damage but do not indicate whether the
membrane is the initial and only target of the AMP or if the
peptide moves past the membrane into the cytoplasm to target
other essential cellular function such as DNA and RNA synthesis.
Barns and Weisshaar (2013) attempted to explain the time
resolved events in pore/channel formation by the membrane
active peptide LL-37 in B. subtilis using single cell, live-imaging
fluorescence microscopy. When a low concentration of LL-37
(2× MIC) was used the growth rate was decreased without
causing membrane permeabilization, but a higher concentration
of LL-37 (4× MIC) caused cell shrinking and permeabilization.
Some of the cells treated with 2× MIC LL-37 had an altered
growth rate but were able to recover. Cells treated with 4×
MIC LL-37 were permeabilized and unable to recover. These
findings suggested that at a low concentration the peptide is able
to interact with the membrane but causes reparable membrane
damage. At a high concentration, a threshold is reached that
causes irreversible membrane damage. The severe membrane
damage that leads to cell shrinking or aberrant septum formation,
probably occurs only at high peptide concentrations. Therefore,
to determine the mode of action of peptides a concentration
range should be selected from lethal to sublethal concentrations
to obtain a broadmechanistic overview of how the peptide targets
the cell.
In the above mentioned study, rhodamine dye labeled LL-
37 (Rh-LL-37) did not have the same antimicrobial effects as
the unlabeled LL-37 against B. subtilis and the mode of action
could thus not be determined using microscopy. Rh-LL-37 was,
however, active against Escherichia coli (Sochacki et al., 2011)
presumably in a similar manner as the unlabeled peptide. The
authors observed that Rh-LL-37 targeted the cells in three phases.
Phase 1 was the fast binding of Rh-LL-37 to the outer membrane
(OM), the lipopolysaccharides (LPS), and O-antigen layers. The
translocation of the peptide over the OM required a threshold
concentration of OM bound peptide. It also appeared that the
peptide was able to move past the OM without causing severe
local OM damage. E. coli growth stopped as soon as Rh-LL-37
entered the periplasmic region, which is known as phase 2. Rh-
LL-37 entered the periplasm at the septal region, where it bound
to immobile elements before it could move past the cytoplasmic
membrane (CM). The immobile elements were suggested to be
peptidoglycan. Phase 3 was the permeabilization of the CM,
which occurred at the septum.
Rh-LL-37 preferably bound to the septating cells instead of
the non-septating cells (Sochacki et al., 2011). Similar results
were obtain for cecropin A (Rangarajan et al., 2013). In addition,
cecropin A was also shown to target the new pole instead of
the old pole (Rangarajan et al., 2013). It is known that the
septum, new pole, and newly formed cells are rich in anionic
phospholipids such as CL (Mileykovskaya and Dowhan, 2010).
This CL-rich domain at the septum is known to recruit the DNA
replication machinery and key cell division proteins such as FtsZ,
FtsA, and ZipA (Lutkenhaus et al., 2012). It is conceivable that
the binding of peptides to CL could cause dissociation of proteins
localized at this region, thus having severe consequences on
cellular homeostasis. A similar study still needs to be performed
on B. subtilis, but it is conceivable that LL-37 or cecropin A also
bind to the cell wall until a threshold is reached, pass the cell wall
in an unknown manner to preferably bind to the membrane at
the septum or new poles.
In another study using fluorescence microcopy, B. subtilis was
exposed to sublethal concentrations of daptomycin which caused
curvature in the structure of the membrane (Pogliano et al.,
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2012). Proteins that recognize negative membrane curvature
such as the cell division protein DivIVA, are bound to these
membrane sites. The combined effect of a curved membrane and
DivIVA localized at these random curved membrane sites caused
alterations in the cell wall and the formation of an additional
septum (Pogliano et al., 2012). Distortion of the cell membrane
and cell wall results in a weakening of these structures causing
the membranes to extrude (forming blebs) (Pogliano et al., 2012).
This could finally cause rupturing of the cell membrane and cell
wall (Pogliano et al., 2012). Interestingly, S. aureus was shown
previously to have an abnormal, asymmetric division septum,
and additional septa in response to daptomycin (Cotroneo et al.,
2008). This study performed by Pogliano et al. (2012) suggests
that in addition to distorting the membrane, membrane bound
proteins could be delocalized thus compromising the normal
functioning of the cell.
A synthetic hexapeptide called MP196 was shown to cause
the delocalization of membrane-bound proteins, such as MurG
that is involved in lipid II biosynthesis (Wenzel et al., 2014).
The delocalization of membrane-bound proteins was thought to
be the result of an altered membrane potential. MP196 interact
with the cell membrane without causing membrane damage
or the eﬄux of ions, but accumulated intracellularly through
an unknown manner. MP196 also targeted the respiratory
chain by detaching cytochrome c from the bacterial membrane.
Abrogation of respiratory chain activity subsequently reduced
ATP synthesis and subsequently macromolecules biosynthesis
(Wenzel et al., 2014).
Taken together these findings suggest that the local membrane
concentration of the peptide plays a key role in the mode of
action of AMPs observed in microscopy. Cardiolipin might play
an important role in the interaction of the AMPs with the cell
membrane that are present at the septum or new pole where
AMPs accumulate. AMPs distort the membrane which leads to
the delocalization ofmembrane localized proteins, such asMurG,
contributing to the death of the cell. Thus, membrane-bound
proteins might also play an important role in the mode of action
of AMPs that has not been fully addressed.
OTHER CELLULAR TARGETS OF AMPs
It is conceivable that AMPs which disrupt the cellular membrane
or translocate to the cytosol without causing membrane damage
can bind to the abundant intracellular polyanionic molecules,
such as the nucleic acids and proteins. For instance, thrombin-
induced platelet microbicidal proteins (tPMPs), from rabbits,
causes limitedmembrane permeabilization but inhibits DNA and
RNA synthesis and hence indirectly protein synthesis (Yeaman
et al., 1998; Xiong et al., 2002). Thrombocidin, from human blood
platelets, was unable to dissipate the membrane potential thus
also suggesting an intracellular target (Krijgsveld et al., 2000).
Similar results were obtained for indolicidin and an AMP that
causes limited membrane permeabilization and inhibits DNA
replication as well as transcription by binding to the DNA duplex,
preventing it from unwinding (Falla et al., 1996; Ghosh et al.,
2014). A synthetic peptide (SP1-1), which was based on natural
α-helical AMPs, was able to move past the cell envelope of S.
aureus into the cytoplasm to interacts with the serine protein
kinase RsbW, an anti-sigma factor (Miyazaki et al., 1999; Dangel
et al., 2013). Various cell processes were affected such as the
induction of cell wall metabolism, oxidative phosphorylation
(cytochrome d), biofilm formation and virulence, and the
repression of amino acid biosynthesis and ABC transporters
involved in antibiotic resistance (Dangel et al., 2013).
AMPs ACTIVITY AGAINST
GRAM-POSITIVE SPORES
To the best of our knowledge anti-spore activity has only been
studied for subtilin produced by B. subtilis (Liu and Hansen,
1993) and for nisin from Lactococcus lactis (Gut et al., 2008).
Nisin and subtilin were only active against germinated spores and
the inner membrane appeared to be the main target (Liu and
Hansen, 1993; Gut et al., 2008, 2011). Disruption of the inner
membrane could be preventing the establishment of metabolism
and the shedding of the spore coat (Gut et al., 2008), thus
preventing outgrowth. In presence of either of the peptides, the
germination receptors were activated, DPA released, water taken
up and the cortex peptidoglycan hydrolyzed before the inner
membrane was exposed to the AMPs. The importance of lipid
II binding for the antimicrobial activity of nisin against spores
was investigated. The results showed that outgrowth inhibition
of B. anthracis spores by nisin was dependent on lipid II binding
as with vegetative cells though in itself the association with the
peptidoglycan precursor was not sufficient for inhibition to be
effective (Gut et al., 2011).
THEORETICAL INTERACTION OF AMPs
WITH GRAM-POSITIVES (BIONUMBERS
AND BIOESTIMATES)
Recently, quantification of cell(wall)-related compounds with
respect to describing cellular physiology in interaction with its
environment has been pursued more and more. Bionumbers and
bioestimates have for instance been described with respect to the
estimation of effects of culturing conditions on the physiology of
Saccharomyces cerevisiae (Klis et al., 2014). Along the same vein,
we explore here the theoretical amount of AMPs that can bind
to or occupy a space on B. subtilis cells or spores. Thus, we aim
to infer the cell components that AMPs could interact with. The
length and width of B. subtilis vegetative cells were obtained from
the Bionumbers database (http://bionumbers.hms.harvard.edu/)
and that of the spores were obtained from results published by
Leuschner and Lillford (2000). The area and volume of vegetative
cells were determined by assuming it has a shape consisting of
a cylinder and two half spheres. The spores were assumed to be
ellipsoidal. The calculated area of vegetative cells was 12.9µm2
in rich medium and 6.3 µm2 in minimal medium (Table 2). The
volume of vegetative cells was 2.6 µm3 in rich medium and 1.6
µm3 in minimal medium. The area and volume of spores is
2.4 µm2 and 0.9 µm3. Calculations can be performed using the
Planetcalc (http://planetcalc.com/149/).
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To estimate the number of AMPs that can bind to the surface
and occupy the space of the cell or spore, membrane disrupting
peptide LL-37 (4 kDa) was employed as an example. LL-37
displayed a MIC value of 1 µM against an inoculum of about
1 × 106 cells (OD600 of 0.0025) in a 100 µl reaction (Barns
and Weisshaar, 2013). The same was assumed for spores. The
number of LL-37 molecules that can target each B. subtilis cell
or spore was estimated to be about 6.0 × 107 molecules. Based
on the calculations of Erickson (2009) of a 5 kDa protein, we
estimated that the 4 kDa LL-37 has a spherical shape with
a radius of about 1 nm. This made it possible to calculate,
for a rough order of magnitude estimation, the number of
LL-37 that can bind to the surface of the vegetative cell or
spore, or fill the intracellular compartments. An hexagonal close
packing formation of the LL-37 molecule was assumed and
the highest density of the arrangement of circles is 0.9 and of
spheres 0.74 (Wells, 1991; Steinhaus, 1999; Chang and Wang,
2010). By dividing the area of the cell surface by the area of
the LL-37 molecule, a maximum number of 3.7 × 106 LL-
37 molecules can cover the surface of a cell cultured in rich
medium and a number of 1.8 × 106 LL-37 molecules covers
the surface of a cell cultured in minimal medium. The volume
was calculated similarly and for cells growing in rich media
a maximum number of 4.5 × 108 LL-37 molecules remain at
disposition to perturb the cell and possibly fill its cytoplasm.
For cells cultured in minimal medium a number of 1.9 ×
108 LL-37 molecules is obtained. Spores can be bound by a
maximum of 6.9× 105 and potentially “filled” by 1.7× 108 LL-37
molecules.
About 3.7 × 106 LL-37 molecules are available to cover the
cell wall surface and 3.7× 106 to cover the cell membrane surface
leaving about 5.3× 107 LL-37molecules still available to partition
into the cytoplasm of a vegetative cell cultured in rich medium.
The B. subtilis vegetative cell is obviously, not an empty object.
The cytoplasm of the cell consist of DNA, RNA, ribosomes,
proteins, a huge number of metabolites, and mobile genetic
TABLE 2 | Bioestimates of the interaction of LL-37 with Bacillus subtilis vegetative cells and spores.
Bacillus subtilis vegetative cell Bacillus subtilis spore
Formula used Estimates Formula used Estimates
Length (l) 4.7 µm or 2.3 µm# 1.4 µm$
Width (w) 0.87 µm# 0.55 µm$
Radius (r) 1/2w 0.44 µm 1/2w 0.28 µm
Volume! (VB.subtilis) Vsphere + Vcylinder =
4/3pir3 + pir2(l – w)
2.6 µm3 or 1.1 µm3 Vellipsoid = 4/3pilwr 0.9 µm
3
Area! (AB.Subtilis) Asphere + Acylinder = 4pir
2
+ 2pir(l – w)
12.9 µm3 or 6.3 µm2 Aellipsoid = 4pi((lw)
1.6+ (lr)1.6+ (wr)1.6)/3)1/1.6 2.4 µm2
Minimal inhibitory
concentration (MIC)
1 µM* 1 µM*
Number of cells 1 × 106* 1 × 106*
Volume 100 µl* 100 µl*
Avogadro’s Number is 6.022 × 1023 per mol 6.022 × 1023 per mol
Amount of molecules
required to inhibit (N)
6.0 × 107 molecules per cell 6.0 × 107 molecules
per spore
Assumed size/radius of
LL-37 (4 kDa)
0.001 µm 0.001 µm
Area of LL-37 (sphere) ALL-37sphere = 4pir
2 1.5 × 10−5 µm2 1.5 × 10−5 µm2
Area of LL-37 (circle) ALL-37circle = pir
2 3.1 × 10−6 µm2 3.1 × 10−6 µm2
Volume of LL-37
(sphere)
VLL-37sphere =4/3pir
3 4.2 × 10−9 µm3 4.2 × 10−9 µm3
Amount of LL-37 that
covers cellˆ
Ahexagonal = 0.9(AB. subtilis/
ALL-37circle)
3.7 × 106 or 1.8 × 106
Amount of LL-37 that
fills the cellˆ
Vhexagonal = 0.6(VB. subtilis/
VLL-37sphere )
4.5 × 108 or 1.9 × 108
Amount of LL-37 that
covers the sporeˆ
Ahexagonal = 0.9(AB. subtilis/
ALL-37circle)
6.9 × 105
Amount of LL-37 that
fills the sporeˆ
Vhexagonal = 0.6(VB. subtilis/
VLL-37sphere )
1.7 × 108
!Assuming that the shape of Bacillus subtilis vegetative cell is a cylinder at the center and has two half spheres at the ends and Bacillus subtilis spores is an ellipsoidal shape.
*Minimal inhibitory concentration obtained from Barns and Weisshaar (2013) and the cell counts are an estimation of the OD600 0.00025 cells used in the study.
#Lenght of B. subtilis is 4.7 µm in rich medium and 2.3 µm in minimal medium. Values obtained from http://bionumbers.hms.harvard.edu/default.aspx.
$Values obtained from Leuschner and Lillford (2000).
ˆAssuming hexagonal close packing of circles or spheres. A value of 0.9 is used to compensate for hexagonal close packing of circles and a value of 0.74 is used for spheres.
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elements that reduces the available space within the cell. Cationic
AMPs can potentially interact with all anionic macromolecules
through electrostatic interaction (Table 3). Therefore, 5.3 × 107
LL-37 molecules could be enough to target at least some of
these components perturbing their normal function in cellular
homeostasis.
The estimation of a maximum of 3.7 × 106 LL-37 molecules
that can bind to the cell wall might also be an underestimation,
since the cell wall is about 33.8 nm thick consisting of multiple
peptidoglycan layers with imbedded teichoic acids. The muramyl
peptides of peptidoglycan layers and the teichoic acids are
anionic, therefore cationic AMPs will interact with all of these
components in each layer before reaching the membrane.
However, as long as the actual affinity constraints are not known
it is unclear what the position is of the equilibrium reactions
TABLE 3 | Bionumbers of the Bacillus subtilis vegetative cell and spore
composition.
Bacillus subtilis References
Vegetative cell Spore
CELL WALL
Thickness 33.8 nm# NA
Teichoic acids 54% SVC Graham and
Beveridge, 1994;
Merchante et al.,
1995
Peptidoglycan 46% SVC
CELL MEMBRANE/INNER MEMBRANE OF SPORE
Protein 62% SVC Bishop et al., 1967
RNA 22% SVC
Phospholipids 16% SVC
Cardiolipin 10% of phospholipid SVC López et al., 2006
Phosphatidylglycerol 25% of phospholipid SVC
Phosphatidylethanolamine 50% of phospholipid SVC
Lysyl-phosphatidylglycerol 15% of phospholipid SVC
CYTOPLASM
DNA 4215 kb SVC Logan and De
Vos, 2015
RNA NA SVC
Ribosomes NA SVC
Protein NA SVC
Mobile genetic elements NA SVC
SPORE COAT
Outer coat layer 40–90 nm Henriques and
Moran, 2000
Inner coat layer 20–30 nm
Protein 10% Munoz et al., 1978
Outer membrane NA
CORTEX
Peptidoglycan NA
#Values obtained from http://bionumbers.hms.harvard.edu/default.aspx.
Similar as vegetative cells (SVC) (Popham, 2002; Setlow, 2006).
Not available (NA).
that the AMPs have with the various components of the cell.
The actual situation maybe anything from a unidirectional
reaction to one where the molecules diffuse more freely,
attaching and detaching more or less stochastically to the binding
sites.
The calculated values suggest that AMPs interact with more
components of the cell than the cell membrane at the MIC value
of LL-37 against B. subtilis. The primary target of the AMP is
the membrane, but the phospholipids comprise only 16% of
the total cell membrane (Refer to Table 2). The cell membrane
also consist of 62% proteins, yet limited information is available
about the interaction of AMPs with these components. It is
likely that AMPs require the distortion of the membrane and the
inactivation of macromolecules in conjunction to have a lethal
effect. For instance, if a maximum of 3.7 × 106 LL-37 molecules
interact with a peptidoglycan layer of 1 nm, a total of 1.3 ×
108 LL-37 molecules could be bound to the 33.8 nm of cell wall
leaving 6.5 × 107 LL-37 molecules available to interact with the
cell membrane. If the calculated maximum number of 3.7 ×
106 LL-37 molecules that can cover the cell membrane surface
is deducted, 6.1 × 107 LL-37 molecules are still available. The
rapid association of the AMPs to the cell might be impairing the
ability to observe all the possible targets of AMPs before cell death
(Brogden, 2005).
AMPs are known to target germinated spores, i.e., when the
cortex has been degraded, the DPA has been released and the
core has been hydrated (Gut et al., 2008). The interaction that
AMPs have with the proteins in the spore coat or with the outer
membrane is not known, but AMPs do interact with the spore’s
inner membrane. The composition of the inner membrane and
the core is similar to the cell membrane and cytosol of vegetative
cells and it can be assumed that AMPs will interact similarly
with spores as with vegetative cells (Popham, 2002; Setlow,
2006).
RESPONSE OF GRAM-POSITIVE
BACTERIA TO THE PRESENCE OF AMPs
Resistance of gram-positives against AMPs is infrequent and
often information gathered about non-susceptible gram-positives
have been used to understand their response to AMPs. Gram-
positives respond to the presence of AMPs mainly through
phenotypic alterations, which involves thickening of the cell wall,
modification of the phospholipid composition, changing of the
net surface charge, increasing the membrane fluidity, releasing
proteinases to degrade the peptides and discharging amino acids
into the environment to reduce hypo-osmotic stress.
In response to AMPs S. aureus and Enterococcus faecalis
thicken their cell wall (Cui et al., 2003, 2006; Kramer et al.,
2004; Yang et al., 2010; Arias et al., 2011; Bayer et al., 2014).
The outer peptidoglycan layer of the thickened cell wall had
a reduced cross-linked structure, which is thought to act like
a molecular sieve preventing AMPs membrane passage (Cui
et al., 2000). S. aureus also increased the content of non-
amidatedmuropeptides in the cell wall peptidoglycan layer which
increase the affinity of the cell wall for AMPs (Cui et al., 2000)
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thereby reducing the peptide’s antimicrobial activity. However,
a thickened cell wall is not always present in non-susceptible
S. aureus strains (Yang et al., 2010) and can be temporary. S.
aureus had a thickened cell wall in response to vancomycin, but
the thickness reduced when vancomycin was removed from the
culturing medium (Cui et al., 2003). The cell walls thickened
again in this strain when vancomycin was reintroduced into the
medium.
S. aureus can also alter its membrane fluidity in response
to AMPs (Jones et al., 2008; Mishra et al., 2012). S. aureus
strains decreased the carotenoid content in their cell membrane
to reduce the membrane’s fluidity in response to daptomycin
(Mishra and Bayer, 2013). Enterococcus faecium had an increase
of unsaturated fatty acids in its cell membrane in response to
daptomycin which reduces membrane fluidity (Mishra et al.,
2012). An increase of cyclopropane fatty acids in E. faecium was
also observed, which is known to be involved in stabilizing the
cell membrane (Glickman et al., 2000; Mishra et al., 2012).
Gram-positives alter their net surface charge by D-alanylation
of the teichoic acids. This has been reported for Streptococcus
gordonii (Chan et al., 2007), C. difficile (McBride and Sonenshein,
2011), S. aureus (Li et al., 2007a; Rose et al., 2012), and B. subtilis
(Pietiäinen et al., 2005). D-alanylation which reduces the anionic
charges of the teichoic acids, is regulated by the dlt operon
(Peschel et al., 1999). The increased susceptibility to cationic
AMPs after deletion of the dlt operon indicates that D-alanylation
of the teichoic acids is one of the mechanisms of S. aureus to
resists peptides. Similar results were obtained for Streptococcus
pneumoniae (Kovacs et al., 2006), B. cereus (Abi Khattar et al.,
2009), and C. difficile (McBride and Sonenshein, 2011). For more
information about the D-alanylation process of teichoic acids
refer to Neuhaus and Baddiley (2003).
The reduction in net surface charge can also be achieved
by modifying the phospholipid composition of the membrane.
E. faecium increased the lysyl-, alanyl- and arginyl-containing
phospholipids and reduced its phosphatidylglycerol (PG)
resulting in a lower negative cell membrane surface charge in
response to daptomycin (Mishra et al., 2012). Similar results
were obtained for S. aureus treated with daptomycin (Peleg
et al., 2012) and E. faecium treated with mundticin KS, a
bacteriocin (Sakayori et al., 2003). Salzberg and Helmann
(2008) caused alterations of the membrane composition of
B. subtilis by deleting various genes involved in the assembly
of the membrane. The mutants lacking MprF were sensitive
to nisin compared to the wild type and a deletion mutant
lacking UgtP was sensitive to sublancin. MprF tranferes a
lysyl group to PG from lysyl-tRNALys to form lysyl-PG and
cardiolipin synthase (CLS) condense two PG molecules to
form CL (Figure 3) (Peschel and Sahl, 2006; Salzberg and
Helmann, 2008). Deleting MprF prevents the synthesis of
lysyl-PG and PG might be consequentially condensed to form
CL or remain PG thus increasing the concentration of CL or
PG in the membrane. In addition to reducing the net negative
charge of the membrane, aminoacylated phosphatidylglycerols
(e.g., lysyl-PG) stabilized the cell membrane (Cox et al.,
2014). UgtP is involved in glycolipid synthesis and glycolipid
is a precursor for LTA, but the cause of the increase in
FIGURE 3 | The partial membrane lipid synthesis pathway of Bacillus
subtilis. The precursor phosphatidic acid (PA), a common precursor for the
membrane phospholipids, is dephosphorylated to diacylglycerol which is
modified by UgtP through transferring one or two glucose molecules from
UDP-glucose resulting in glycolipid (GL). Phosphotidylglycerol (PG) is
converted to lysyl-PG when a lysyl group from lysyl-tRNALys is transferred to
PG by MprF. PG is also converted to cardiolipin by combining two PG
molecules. Image adjusted from Salzberg and Helmann (2008).
subtilin sensitivity of the deletion mutant lacking UgtP was
unclear.
Previously, an mprF deletion mutant of S. aureus showed
sensitivity to defensin and protegrin (Peschel et al., 2001). In S.
aureus stains an increase in L-PG synthesis was only achieved
after a point mutation in a certain regions in the mprF operon
that caused an MprF gain-of-function phenotype (Yang et al.,
2010; Bayer et al., 2014). The S. aureus stains with the MprF
gain-of-function phenotype were also less sensitive to tPMPs and
human neutrophil peptide 1 (hNP-1; defensin) from neutrophils
(Bayer et al., 2014). MprF is present in various bacterial genomes
and the modification is considered to be a general strategy
against AMPs (Peschel and Sahl, 2006). However, reducing the
net negative charge of themembrane has a limit and bacteria with
reduced peptide susceptibility can still be killed by increasing the
concentration of the AMPs.
The production of proteinases that degrade AMPs has been
reported for certain bacterial species such as Pseudomonas
aeruginosa, E. faecalis, Proteus mirabilis, and Streptococcus
pyogenes (Schmidtchen et al., 2002). S. aureus produces a
metalloproteinase (aureolysin) that degrades LL-37 rendering it
inactive (Sieprawska-Lupa et al., 2004). S. aureus inhibits α-
defensin by releasing staphylokinase that binds to the peptide
to form a complex (Jin et al., 2004). S. pyogenes produce a
cysteine proteinase called SpeB, that is bound to the cell surface
and degrades LL-37 which made contact with the cell envelope
(Nyberg et al., 2004). P. aeruginosa, E. faecalis, and S. pyogenes
inactivated α-defensin by generating dermatan sulfate that binds
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to the peptide (Schmidtchen et al., 2001). These bacteria produce
dermatan sulfate by releasing proteinases degrading dermatan
sulfate-containing proteoglycans, such as decorin (Schmidtchen
et al., 2001).
Bacillus subtilis Cell Envelope Stress
Response to AMPs
Phenotypic alterations brought about in response to AMPs are
mainly due to the reaction of a signal-transducing regulatory
system that induces countermeasures to repair damage and
protect the cell in response to cell envelope alterations and
abnormalities (Jordan et al., 2008). B. subtilis regulates its stress
response with the extracytoplasmic function (ECF) sigma factors
and a two component system (TCS) (Jordan et al., 2008; Kingston
et al., 2011). Both are signaling systems that consist of a
membrane-bound sensor kinase and a response regulator (Jordan
et al., 2008). The regulator remains inactive in conditions that do
not cause cell envelope stress, but as soon as envelope stress is
detected the regulator is activated and induces the expression of
its target genes.
In response to sublethal concentrations of LL-37, B. subtilis
activated the SigM and SigW regulons controlled by the ECF
sigma factors (Pietiäinen et al., 2005). The SigM regulon is
activated by cell wall antibiotics, acidic pH, heat, ethanol,
superoxide, and cell envelope stress (Cao and Helmann, 2002;
Minnig et al., 2003; Thackray and Moir, 2003). It is involved in
activating various genes involved in cell wall biosynthesis, cell
division and cell shape, DNA damage response and detoxification
enzymes (Eiamphungporn and Helmann, 2008). SigW is also
induced by the presence of cell wall active antibiotics, such
vancomycin, and by the membrane active AMP PG-1 and
alkaline shock (Wiegert et al., 2001; Cao and Helmann, 2002;
Pietiäinen et al., 2005). SigW regulates the alteration of the
fatty acid composition of the cell membrane that results in a
reduced or increased membrane fluidity (Kingston et al., 2011).
Peptide PG-1 activated SigM and SigX in B. subtilis (Pietiäinen
et al., 2005). SigX is involved in regulating the overall net charge
of the envelope as it steers the dltABCDE and pssA-ybfM-psd
operons (Cao and Helmann, 2004). As mentioned before, the dlt
genes control D-alanylation of the LTA and PssA/Psd catalyzes
the synthesis of phosphatidylethanolamine (PE). The combined
effect is a less negatively charged cell membrane (Cao and
Helmann, 2004).
In addition to the activation of ECF sigma factors, two
component systems were activated. LL-37 activated the two
component system YxdJK TCS and LiaRS (YvqCE) TCS
(Pietiäinen et al., 2005). The two-component system activated
by B. subtilis is dependent on the peptide. For instance, the
membrane targeting peptide PG-1 activated only LiaRS (YvqCE)
TCS and not the YxdJK TCS (Pietiäinen et al., 2005). The
LiaRC TCS and ECF sigma factors are a cell wall antibiotic-
response system responsible for preserving cell envelope integrity
and prevention of cell envelope damage (Jordan et al., 2008).
These systems’ regulon is diverse and does not mediate a specific
antibiotic resistance (Jordan et al., 2008). The role that these
systems have are to maintain homeostasis (Jordan et al., 2008).
B. subtilis has three TCS/ABC transporter modules; the
BceRS-BceAB, the YvcPQ-yvcRS, and YxdJK-yxdLM systems
(Joseph et al., 2002; Mascher, 2006). The ABC transporter
involved in the BceRS system is specific for the removal of
bacitracin from the cell envelope (Mascher et al., 2003; Ohki et al.,
2003). The process of bacitracin removal is still unknown, but
a hydrophobic vacuum cleaner model has been suggested which
involves the removal of bacitracin by a transporter directly from
the phospholipid bilayer to extracellular environment (Bolhuis
et al., 1996; Ohki et al., 2003). BceRS was also induced by
other cell wall synthesis inhibiting peptides such as plectasin,
mersacidin and actagardine (Staron´ et al., 2011). The YxdJK-
yxdLM system is activated by LL-37 (Pietiäinen et al., 2005).
The role of this system has not been identified yet (Jordan et al.,
2008). The YvcPQ-yvcRS system is activated in response to lipid
II-binding lantibiotics such as nisin and gallidermin (Staron´ et al.,
2011), but its role is unknown.
Other genes that were also upregulated in response to LL-
37 are the bcrC (ywoA) gene involved in cell wall synthesis and
bacitracin resistance (Pietiäinen et al., 2005), pbpE (penicillin-
binding protein) that is known to be induced by cell wall stress
(Cao et al., 2002) and dltB which is like the dlt operon (Pietiäinen
et al., 2005). Concluding, B. subtilis respond to the onslaught of
AMPs by reducing the net negative charge of the cell surface,
by attempting to maintain cell envelope homeostasis and by
removing the AMPs from the cell surface.
Staphylococcus aureus Cell Envelope
Stress Response to AMPs
To obtain insight whether other gram-positive bacteria responds
similarly to B. subtilis to the presence of AMPs, the response
of Staphylococcus sps. was reviewed. In response to cationic
peptides, S. epidermis and S. aureus showed to activate, similar
to B. subtilis, a two-component sensor/regulator system called
the aps system (Li et al., 2007a,b; Yang et al., 2012). The aps
(graRS) regulated gene loci have been associated with resistance
against cationic AMPs such as defensin, indolicin and LL-37. The
aps system consist of three components known as ApsS, ApsR,
and ApsX (Li et al., 2007a,b). The aps system regulates the dlt
operon, the mprF gene, and vraFG, a putative ABC transporter-
dependent eﬄux pump, thought to be exclusively involved in
AMP resistance (Li et al., 2007a,b; Yang et al., 2012). In addition
to aps system role as regulatory system, the extracellular sensing
loop of ApsS has a high density of negative charges that binds to
peptides, directly rendering the AMP inactive (Li et al., 2007a,b).
Yang et al. (2012) reported that these phenotypic changes brought
about by the aps system to a single AMP could also cause
cross-resistance to another AMP that is structurally different.
CONCLUSION
In conclusion, cationic AMPs can cause membrane perturbation,
which can either cause physical damage to the membrane or
may leave the membrane intact. In both cases the membrane
potential can be lost or ion eﬄux can take place. Peptides
that traverse the membrane do not always cause eﬄux of ions.
Cationic AMPs have been shown to target the septum and new
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poles (Skerlavaj et al., 1999; Sochacki et al., 2011; Rangarajan
et al., 2013), and to cause delocalization of membrane-bound
proteins (Wenzel et al., 2014) or localization of proteins at
incorrect sites at the membrane (Pogliano et al., 2012). The
latter has been confirmed with the formation of abnormal septa
(Friedrich et al., 2000; Nakajima et al., 2003; Pogliano et al.,
2012). Cationic AMPs do bind to macromolecules (DNA, RNA
or protein) and thus prevent the normal functioning of the cell
(Falla et al., 1996; Miyazaki et al., 1999; Xiong et al., 2005; Dangel
et al., 2013; Ghosh et al., 2014). AMPs also inhibited cell wall
biosynthesis without causing membrane damage by binding to
lipid II and induce autolysis. Additionally, antimicrobial activity
of AMPs have been observed against spores but only if these have
previously germinated.
The bionumbers and bioestimates was utilized to obtain a
rough order ofmagnitude estimation of the number of AMPs that
can target the vegetative B. subtilis cell or spore at theMIC values.
The calculations suggested that a maximum of 6.0 × 107 LL-37
molecules can target each vegetative cell or spore at the MIC
value of 1 µM. When the theoretical surface area and volume
of the vegetative cell or spore was calculated, a maximum of
3.7 × 106 LL-37 molecules was estimated to cover the surface
area of the vegetative cell in a hexagonal packing formation
when the cell has been cultured in rich medium. When this
maximum number of LL-37 molecules were deducted from the
cell wall and cell membrane surface area, the results showed
that at MIC more LL-37 molecules are available to target the
vegetative cell than what is required for membrane binding.
Even when the bionumber of the cell wall was also taken into
consideration. These calculations suggest that LL-37 targets more
cell components than the cell membrane, even if some of the
peptides should get trapped in the thick cell wall. Hence it is
highly likely that intracellular macromolecules are also targeted
at the MIC value. However, the LL-37 molecules might also be
bound to the surface of the test tube or the well of the microtiter
plate, or be bound to components of the culturing medium.
If this is the case, than the actual number of LL-37 molecules
targeting the cell may obviously be less than what has been
calculated.
The response of some gram-positives to the attack by cationic
AMPs is to thicken their cell wall thus entrapping peptides or
even to create an affinity trap. The bacteria may reduce their
membrane fluidity to prevent insertion of peptides into the
membrane or to stabilize it. Released amino acids may reduce
the hypo-osmotic pressure caused by the interaction of the
AMPs with the cell membrane. Some gram-positives reduce their
anionic net charge by modifying their phospholipid composition
or by D-alanylating their teichoic acids to repel the cationic
peptides. Most of these physical alterations have been confirmed
though transcriptomic or proteomic approaches and it appears
that the bacteria respond to AMPs by activating their general cell
envelope stress response and by removing the AMPs from the cell
surface.
However, to increase our understanding of the mode of action
of AMPs or the response of bacteria to AMPs more information
is required. For now the use of fluorescence microscopy and real-
time single cell live imaging has already given more information
concerning the mode of action of AMPs than what TEM or
SEM have initially provided (Sochacki et al., 2011; Pogliano
et al., 2012; Barns and Weisshaar, 2013; Rangarajan et al., 2013).
Furthermore, a new area of considerable importance for the
medical field as well as for food safety is the action of AMPs
on bacterial spores. The limited information available on the
mode of action of AMPs against spores indicates AMPs target
only germinated spores, but there may be AMPs with different
modes of anti-spore activity. Quantitatively there is a need for
data, for example pre-steady state kinetics, on the interaction
strength or affinity constraints of AMPs with the various cell
components. Also the further development of traceable AMPs
that retain their normal antimicrobial activity will benefit our
attempt to increase our understanding of the mode of action of
AMPs.
A better understanding of the modes of action of various
AMPs will improve the design of AMPs aimed for use as
antimicrobial agents. Having a solid knowledge base of the
response of different bacteria to these peptides will provide
information on what to expect when bacteria do develop
resistance during the clinical use of AMPs or their possible
application as preservative in the food chain.
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